Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Interstitial Cystitis/Painful Bladder Syndrome
NCT06209008Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2021
- Primary completion
- Apr 2023
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of platelet-rich plasma in interstitial cystitis (IC), sponsored by Ain Shams University. Primary endpoints: Global Response Assessment at 6 months and Visual Analogue Scale at 6 months. Started Apr 2021; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT06209008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06209008.